États-Unis · Plateformes & données · TipRanks

Pfizer Stock (PFE) Rises on Q3 Earnings Beat and Raised 2026 Sales Outlook

Publié par TipRanks · États-Unis il y a 9 h

Pfizer shares (PFE) edged higher in Tuesday’s pre-market session after the U.S. pharma giant reported a Q3 2026 earnings beat and raised its sales forecast. The company now…

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Pfizer Stock (PFE) Rises on Q3 Earnings Beat and Raised 2026 Sales Outlook

À lire aussi

Tech borrowers are picking up the tab: debt premium hits a 23-year high

Texas governor race tightens in prediction markets, but Abbott remains favored

Astec Industries, Inc. (NASDAQ:ASTE) Plans Quarterly Dividend of $0.13

ICF vs. HAUZ: ICF Beats on Returns, but HAUZ Dominates on Fees and Yield

Treasury yields edge up as Election Day meets JOLTS, refunding

Best Biotech Stocks Right Now

Pfizer Stock (PFE) Rises on Q3 Earnings Beat and Raised 2026 Sales Outlook

Partager

À lire aussi

Tech borrowers are picking up the tab: debt premium hits a 23-year high

Texas governor race tightens in prediction markets, but Abbott remains favored

Astec Industries, Inc. (NASDAQ:ASTE) Plans Quarterly Dividend of $0.13

ICF vs. HAUZ: ICF Beats on Returns, but HAUZ Dominates on Fees and Yield

Treasury yields edge up as Election Day meets JOLTS, refunding

Best Biotech Stocks Right Now